Digital Health, Technology & InnovationFujirebio Launches Lumipulse® G pTau 217 CSF Assay RUOBusiness WireJanuary 29, 2026January 30, 2026 by Business WireJanuary 29, 2026January 30, 2026017 H.U. Group Holdings Inc. and its wholly-owned subsidiary Fujirebio today announced the availability of the Lumipulse G pTau 217 CSF assay for the fully automated...
